Mechanisms of Type 1 Diabetes Endophenotypes

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions
Type 1 Diabetes MellitusGenetic Predisposition to Disease
Interventions
GENETIC

Genome sequencing

"100 extensively phenotyped pediatric and young adult patients for genotyping, metabolomic and lipidomic analyses. Polygenic risk scores for type 1 diabetes and cardiovascular disease will be performed.~For patients older than 6 years who agree to do a second visit (optional), a Mixed Meal Tolerance Test (MMTT: the gold standard for assessing beta cell function) will be done as well as transcriptomic analysis."

Trial Locations (1)

1205

RECRUITING

University Hospital of Geneva, Geneva

All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

collaborator

University of Geneva, Switzerland

OTHER

lead

Pediatric Clinical Research Platform

OTHER